Loading clinical trials...
Loading clinical trials...
Nalbuphine Versus Midazolam as an Adjuvant to Intrathecal Bupivacaine for Postoperative Analgesia in Patients Undergoing Cesarean Section
Conditions
Interventions
Bupivacaine
Nalbuphine
+1 more
Locations
1
Egypt
Olfat Abd Elmoniem Ibrahem Amin
Zagazig, Eygpt/zagazig, Egypt
Start Date
April 10, 2019
Primary Completion Date
August 30, 2019
Completion Date
December 1, 2019
Last Updated
December 24, 2019
Lead Sponsor
Zagazig University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions